Profil
Benedikt Stefansson is currently Senior Director-IR & Global Communication at Alvotech since 2022.
Formerly, Mr. Stefansson was Vice President-Sales & Marketing at deCODE genetics, Inc., Research Analyst at Landsbanki Research, and Head-Business Development at CRI hf.
Mr. Stefansson completed graduate studies at the University of California, Los Angeles.
Postes actifs de Benedikt Stefansson
| Sociétés | Poste | Début |
|---|---|---|
| ALVOTECH | Investor Relations Contact | 02/03/2022 |
Anciens postes connus de Benedikt Stefansson
| Sociétés | Poste | Fin |
|---|---|---|
CRI hf.
CRI hf. Chemicals: SpecialtyProcess Industries Designs, licenses and sells emissions-to-liquids (ETL) process technology for producing green methanol | Corporate Officer/Principal | - |
deCODE genetics, Inc.
deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology Is a bio-pharmaceutical company | Sales & Marketing | - |
Landsbanki Research | Analyst-Equity | - |
Formation de Benedikt Stefansson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
deCODE genetics, Inc.
deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology Is a bio-pharmaceutical company | Health Technology |
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Landsbanki Research | |
CRI hf.
CRI hf. Chemicals: SpecialtyProcess Industries Designs, licenses and sells emissions-to-liquids (ETL) process technology for producing green methanol | Process Industries |
Alvotech
Alvotech BiotechnologyHealth Technology Develops biologic medicines | Health Technology |
















